Pancreatic cancers are among the most aggressive, deadly tumor types, and for years, researchers have struggled to develop effective drugs against the tumors. Now, Salk Institute researchers have identified a new set of molecules that fuel the growth of tumors in pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
